Table 2 Clinical characteristics of DM patients with satisfactory (HbA1c < 6.5%) or poor (HbA1c≥6.5%) glycemic control
|  | HbA1c < 6.5% (n = 120) | HbA1c≥6.5% (n = 114) | P-value |
|---|---|---|---|
Age, years | 56.5 ± 8.5 | 56.8 ± 8.4 | 0.81 |
Males, n (%) | 62 (52) | 57 (50) | 0.35 |
Hypertension, n (%) | 40 (33) | 58 (51) | < 0.05 |
Hypercholesterolemia, n (%) | 52 (43) | 62 (54) | < 0.01 |
Ever-smokers, n (%) | 29 (24) | 43 (38) | < 0.01 |
Duration of DM, yrs | 9.7 ± 7.0 | 10.3 ± 8.6 | 0.37 |
Body-mass index, kg/m2 | 25.4 ± 4.3 | 24.9 ± 5.2 | 0.48 |
Waist-hip circumference ratio | 0.9 ± 0.1 | 0.9 ± 0.1 | 0.38 |
Body weight, kg | 64.2 ± 11.7 | 65.6 ± 10.3 | 0.52 |
Systolic blood pressure, mmHg | 145.2 ± 23.2 | 143.1 ± 18.5 | 0.45 |
Diastolic blood pressure, mmHg | 77.9 ± 7.8 | 80.4 ± 9.5 | 0.08 |
Fasting blood glucose, mmol/L | 5.7 ± 1.2 | 8.5 ± 2.3 | < 0.01 |
HbA1c, % | 6.1 ± 0.5 | 8.8 ± 1.3 | < 0.01 |
Triglyceride, mmol/L | 1.5 ± 1.1 | 1.7 ± 1.3 | 0.18 |
Total cholesterol, mmol/L | 4.6 ± 0.9 | 4.5 ± 0.9 | 0.27 |
LDL-C, mmol/L | 2.6 ± 0.8 | 2.5 ± 0.7 | 0.21 |
HDL-C, mmol/L | 1.3 ± 0.4 | 1.2 ± 0.4 | 0.06 |
Creatinine, μmol/L | 82.8 ± 21.6 | 85.7 ± 31.0 | 0.42 |
GFR, ml/min/1.73m2 | 56.4 ± 12.1 | 55.0 ± 17.2 | 0.39 |
Beta-blocker, n (%) | 56 (47) | 50 (44) | 0.34 |
Calcium channel blocker, n (%) | 35 (29) | 42 (37) | 0.08 |
ACEI/ARB, n (%) | 57 (48) | 65 (57) | 0.06 |
Aspirin, n (%) | 48 (40) | 55 (48) | 0.13 |
Statin, n (%) | 57 (48) | 62 (54) | 0.11 |
Insulin, n(%) | 9 (8) | 26 (23) | < 0.01 |
Log CD34/KDR+ EPCs, 10-3/ml | 1.05 ± 0.27 | 0.88 ± 0.32 | < 0.01 |
Log CD133/KDR+ EPCs, 10-3/ml | 0.78 ± 0.28 | 0.61 ± 0.21 | < 0.01 |
Log baPWV, cm/s | 3.23 ± 0.08 | 3.27 ± 0.09 | < 0.05 |